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1. Introduction
   Echinococcosis (hydatid disease) is a zoonotic parasitic 
disease of human and mammalians caused mainly by the 
larval stage of dog tapeworm Echinococcus granulosus. 
The common sheep/dog cycle is usually considered as 
the major source of human contamination. The definitive 
hosts (dogs) harboring the adult worms in their intestinal 
tract. The worms pass eggs in the dog stool, which 
are ingested by herbivores or humans; the eggs hatch 
releasing larvae (oncosphere) that invade through the 
intestinal wall and evolve to hydatid cysts. Herbivores 
play a suitable intermediate host. Within the fertile cysts 
are the protoscoleces derived from the germinal layer, 
which if ingested by a dog evaginate and develop into 
adult worms[1-3]. The parasite is prevalent in areas where 
livestock is raised in association with dogs including 
Australia, Latin America, Eastern Europe, Africa and the 
Middle East[4].
   There is a lack of information about the prevalence, 
epidemiology and clinical pattern of human hydatidosis 
in most gulf countries particularly in Qatar. So this 
retrospective study was prompted to conduct to 
determine the prevalence and to describe the clinical 
findings, diagnostic methods, treatment, and outcome of 
human hydatidosis in Qatar.
2. Materials and methods
2.1. Setting
   This study was conducted at Hamad General Hospital 
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in Qatar from 2000 to 2013. This hospital, which was 
accredited by Joint Commission International in 2006, 
is a tertiary centre that covers all specialties except for 
hematology-oncology and obstetrics. It includes six 
intensive care units, which provide a full range of clinical 
services in different departments of surgery and internal 
medicine.
2.2. Study design, population and data source
   This study involved all patients admitted to Hamad 
General Hospital with hydatid disease from 1st January 
2000 to 31st December 2013. The cases were identified 
retrospectively by review of pharmacy, infection control 
unit and hospital discharge records. This was followed by 
a retrospective chart review. 
2.3. Data collection and statistical analysis
   Data were collected into a special form, including 
demographic data, clinical presentation, investigations 
done, treatment received and outcome (30-d mortality 
and cure). 
   The data were analyzed with SPSS 11.00 software (SPSS, 
Inc., Chicago, IL, US) using simple descriptive statistics.
2.4. Research committee approval
   This study was given ethical approval by the medical 
research committee at Hamad Medical Corporation. As 
the study was retrospective, a waiver of informed consent 
was obtained from the research committee.
3. Results
   During the period of study, hydatid disease was 
confirmed in 32 patients. The mean age of them was (35.59
依13.00) years (range: 11-67 years) and 90.6% (29/32) of them 
were non-Qataris with male predominance (M/F: 20/12) 
(Table 1). The maximum number of patients was found in 
the age group of 25-34 years. 
   The main presenting symptom was abdominal pain 
71.9% (23/32) followed by fever 45.9% (15/32). The main 
presenting sign was hepatomegaly 62.5% (20/32). Single 
organ involvement was found in 87.5% (28/32) and the 
common site involved was the liver 81.3% (26/32) followed 
by the lung 15.6% (5/32). The diagnosis was established 
by abdominal ultrasound and/or abdominal CT and 
serology in all patients. The diagnosis was confirmed by 
histology in 90.6% (29/32) patients. All patients received 
albendazole, and 90.6% (29/32) patients had surgical 
intervention. Duration of albendazole therapy was (53.9
依51.5) d (range: 28-180 d). All patients cured, and no 
mortalities have been found. 
Table 1
Demographic and clinical characteristics of patients involved in this 
study.
Variable N (%)/Mean依SD
Sex (M/F)      20/12
Age (mean依SD) (years) 35.59依13.00
Age group
0-14    1 (3.1%)
15-24   5 (16.1%)
25-34 12 (37.5%)
35-44   8 (25.0%)
≥45   6 (19.4%)
Presenting symptoms and signs
Abdominal pain 23 (71.9%)
Fever 15 (46.9%)
Vomiting 12 (37.5%)
Anorexia   8 (25.0%)
Dyspnea   5 (15.6%)
Hemoptysis    3 (9.4%)
Chest pain    3 (9.4%)
Hematemesis    1 (3.1%)
Hepatomegaly 20 (62.5%)
Splenomegaly     2 (6.3%)
Jaundice       2 (6.3%)
WBC: white blood cell, US: ultrasonography.
Table 1, continued
Variable N (%)/Mean依SD
Investigations
WBC>11 000/µL   7 (21.9%)
Eosinophilia>1 000/µL   6 (18.8%)
Total bilirubin (>34 µmol/L)   5 (15.6%)
Suggested by imaging studies 
(US&CT) 
 32 (100%)
Positive serology  32 (100%)
Positive histology 29 (90.6%)
Sites involved
Liver 26 (81.3%)
Lung   5 (15.6%)
Kidney     2 (6.3%)
Spleen     2 (6.3%)
Other sites      3 (9.4%)
Comorbidities     3 (9.4%)
Treatment
Medical  32 (100%)
Surgical 29 (90.6%)
Mortality 0
WBC: white blood cell, US: ultrasonography.
Ahmed  Mohamad Al-Ani et al./Asian Pac J Trop Med 2014; 7(Suppl 1): S85-S87 S87
4. Discussion
   The actual incidence of human hydatidosis in Qatar is 
not known accurately. A careful retrospective study of 
hospital records from 1st January 2000 to 31st December 
2013, identified 32 cases, 90.6% of them are non-Qataris 
from endemic areas.
   Lifecycle of the parasite in Middle East countries 
depends on the facility to reach discarded entrails 
of livestock by dogs (especially stray dogs). In Qatar, 
although all sheep and goats are imported from endemic 
countries for hydatid disease such as Saudi Arabia, Syria, 
Jordan, Iran, Oman and Somali, all slaughterhouses are 
under health authorities’ strict supervision. From 2006 
to 2013, health authority discovered 9 202 (9003 in Table 
2) infected animals (Table 2). The contaminated entrails 
of the slaughtered sheep and goats usually are treated 
chemically and buried underground. Moreover, there are 
no stray dogs in Qatar. This makes the occurrence of this 
disease indigenously in Qatar unlikely. Thus we think 
that all cases in this study are imported.  
   In consistent with some studies from Iran, Greece 
and India[1,4-6], abdominal pain was the most common 
symptom and liver was the most frequently involved site. 
In Mauritania, the pulmonary localization seems to be the 
most frequent[7]. The unusual location of primary hydatid 
disease such as thyroid gland, heart and intraperitoneal 
is still a diagnostic challenge[6,8,9].  
Table 2
Number of reported Hydatid disease infected animals between 2006-
2013.
Years Number of cases
2006  770
2007  325
2008  680
2009  702
2010  652
2011 1182
2012 1331
2013 3561
All reported cases above were found in livers of goats and sheep 
exported from different origin including Syria, Saudi Arabia, Iran, 
Somalia and Oman. 
   In the diagnost ic  workup of  hydatid disease, 
ultrasonography, CT and magnetic resonance image are 
helpful in establishing the diagnosis. The diagnosis 
of hydatid disease is based mostly on imaging with 
ultrasonography with sensitivity ranges between 93% 
and 98%[10]. CT confirms the diagnosis by detecting the 
presence of daughter cysts and calcification in cyst wall 
with sensitivity ranges between 90% and 97%[10]. Magnetic 
resonance image demonstrates the features of the cyst 
adequately.  
   The serological tests for Echinococcus granulosus are 
available with low sensitivity and specificity. 
   In this study, the diagnosis was established by 
abdominal ultrasound and/or abdominal CT and serology 
in all patients.
   Treatment comprises mainly surgical intervention or 
percutaneous treatment and/or high dose, long-term 
therapy with albendazole alone or in combination with 
praziquantel[11]. Surgery, conservative or radical, has 
been the traditional approach for treatment of the disease 
in all locations[6]. In the series, all patients received 
albendazole and 90.6% (29/32) patients had surgical 
intervention with a variety of techniques.
   In conclusion, hydatid disease is uncommon in Qatar. 
It occurs mainly among non-Qataris from endemic areas 
and affects the liver mostly. Surgical intervention and 
albendazole administration are highly effective.    
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